Mydecine Innovations Group Inc.
Profile
Mailing Address: Suite 810 - 789 West Pender Street
Vancouver, BC
V6C 1H2
Head Office Address: Suite 810 - 789 West Pender Street
Vancouver, BC
V6C 1H2
Contact Name: Joshua Bartch Principal Regulator: British Columbia
Business e-mail address: jbartch@mydecineinc.com Short Form Prospectus Issuer: Yes
Telephone Number: 604 687-2038 Reporting Jurisdictions: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland
Fax Number: Stock Exchange: Canada - Aequitas Neo Exchange
Date of Formation: Sep 27 2013 Stock Symbol: MYCO
Jurisdiction Where Formed: British Columbia Auditor: MNP LLP
Industry Classification: agricultural industries General Partner:
CUSIP Number: 62848R Transfer Agent: National Securities Administrators Ltd
Financial Year-End: Dec 31 Size of Issuer (Assets): Under $5,000,000


View This Company's Documents